These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35592052)

  • 1. Immunotherapy using Histobulin™ in psoriasis: A case report.
    Kim HS; Noh G
    Clin Case Rep; 2022 May; 10(5):e05831. PubMed ID: 35592052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of remission in chronic urticaria by immunotherapy using immunoglobulin/histamine complex (Histobulin™): a case report.
    Kim HS; Noh G
    Allergy Asthma Clin Immunol; 2021 Nov; 17(1):116. PubMed ID: 34772446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world treatment patterns and healthcare costs among biologic-naive patients initiating apremilast or biologics for the treatment of psoriasis.
    Wu JJ; Pelletier C; Ung B; Tian M
    J Med Econ; 2019 Apr; 22(4):365-371. PubMed ID: 30652520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of plaque psoriasis with biologics. A meta-analysis of randomized controlled trials].
    Zhang Z; Schmitt J; Wozel G; Kirch W
    Med Klin (Munich); 2009 Feb; 104(2):125-36. PubMed ID: 19242664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cure of Psoriasis and Arthritis when Addison's Disease Was Detected.
    Lind M
    Case Rep Dermatol; 2010 Jun; 2(2):95-98. PubMed ID: 21103194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved HPLC Method Using 2,3-naphthalenedicarboxaldehyde as Fluorescent Labeling Agent for Quantification of Histamine in Human Immunoglobulin Preparations.
    Kim JH; Shin IS; Lee YK; Oh HJ; Ban SJ
    Osong Public Health Res Perspect; 2011 Sep; 2(2):127-34. PubMed ID: 24159462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis Exacerbation after
    Sarsik SM; Soliman SH
    Skin Appendage Disord; 2021 Apr; 7(3):212-215. PubMed ID: 34055910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologics are more potent than other treatment modalities for improvement of quality of life in psoriasis patients.
    Takahashi H; Iinuma S; Tsuji H; Honma M; Iizuka H
    J Dermatol; 2014 Aug; 41(8):686-9. PubMed ID: 25040258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to biologics in patients with psoriasis.
    Seale L; Cardwell LA; Feldman SR
    Expert Rev Clin Immunol; 2018 Feb; 14(2):155-161. PubMed ID: 29327643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of biologic agents for psoriasis in patients with viral hepatitis.
    AlMutairi N; Abouzaid HA
    J Dermatolog Treat; 2018 Sep; 29(6):553-556. PubMed ID: 29345515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining Topical Psoriasis Treatment to Enhance Systemic and Phototherapy: A Review of the Literature.
    Bagel J; Gold LS
    J Drugs Dermatol; 2017 Dec; 16(12):1209-1222. PubMed ID: 29240856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multinational, prospective, observational study to estimate complete skin clearance in patients with moderate-to-severe plaque PSOriasis treated with BIOlogics in a REAL world setting (PSO-BIO-REAL).
    Seneschal J; Lacour JP; Bewley A; Faurby M; Paul C; Pellacani G; De Simone C; Horne L; Sohrt A; Augustin M; Hammond E; Reich K
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2566-2573. PubMed ID: 32364296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of severe facial psoriasis with adalimumab.
    Noiles K; Vender R
    J Drugs Dermatol; 2008 Dec; 7(12):1165-7. PubMed ID: 19137771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An hypothesis explaining the successful treatment of psoriasis with thermal biofeedback: a case report.
    Goodman M
    Biofeedback Self Regul; 1994 Dec; 19(4):347-52. PubMed ID: 7880910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis treatment using minimally manipulated umbilical cord-derived mesenchymal stem cells: A case report.
    Ahn H; Lee SY; Jung WJ; Pi J; Lee KH
    World J Clin Cases; 2021 Aug; 9(23):6798-6803. PubMed ID: 34447827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologics and dermatology life quality index (DLQI) in the Australasian psoriasis population.
    Norris D; Photiou L; Tacey M; Dolianitis C; Varigos G; Foley P; Baker C
    J Dermatolog Treat; 2017 Dec; 28(8):731-736. PubMed ID: 28489479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission of psoriasis after allogeneic, but not autologous, hematopoietic stem-cell transplantation.
    Kaffenberger BH; Wong HK; Jarjour W; Andritsos LA
    J Am Acad Dermatol; 2013 Mar; 68(3):489-92. PubMed ID: 22981608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of treatment-sequence model with a customizable number of treatments to better reflect contemporary and future clinical practice in moderate to severe psoriasis.
    van de Wetering G; Ignacio T; Dhanda D; Patel V; Zhang Y; Zhuo J
    J Med Econ; 2022; 25(1):421-427. PubMed ID: 35297738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in men.
    Hägg D; Eriksson M; Sundström A; Schmitt-Egenolf M
    PLoS One; 2013; 8(5):e63619. PubMed ID: 23691076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustainability and switching of biologics for psoriasis and psoriatic arthritis at Fukuoka University Psoriasis Registry.
    Bayaraa B; Imafuku S
    J Dermatol; 2019 May; 46(5):389-398. PubMed ID: 30861182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.